Simplex Trading
CGON icon

Simplex Trading’s CG Oncology CGON Stock Holding History

Simplex Trading’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1K Sell
400
-2,300
-85% -$130K ﹤0.01% 6495
2025
Q4 		$112K Buy
2,700
+1,600
+145% +$66.2K ﹤0.01% 4882
2025
Q3 		$44K Sell
1,100
-1,000
-48% -$29.1K ﹤0.01% 6582
2025
Q2 		$54K Hold
2,100
– – ﹤0.01% 5846
2025
Q1 		$51K Buy
2,100
+700
+50% +$19.7K ﹤0.01% 5746
2024
Q4 		$40K Buy
1,400
+200
+17% +$6.84K ﹤0.01% 6090
2024
Q3 		$45K Buy
1,200
+500
+71% +$17.5K ﹤0.01% 5968
2024
Q2 		$22K Buy
+700
New +$24.3K ﹤0.01% 6797

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Simplex Trading's CGON Position: Q3 2024 in Review

Simplex Trading sold out of CG Oncology (CGON) in Q3 2024, closing a stake of 264 shares — an estimated $9.26K sold.

Simplex Trading first reported a position in CGON in Q2 2024 and held it in 1 quarter. The position peaked at $8K in Q2 2024. 121 funds tracked by Wall St. Rank hold CGON as of Q3 2024.

  • Simplex Trading reported no remaining CG Oncology position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 264 CG Oncology shares in Q3 2024, an estimated $9.26K.
  • Simplex Trading first reported a position in CG Oncology in Q2 2024 and held it in 1 quarter.
  • Simplex Trading's CG Oncology position peaked at $8K in Q2 2024.
  • 121 funds tracked by Wall St. Rank held CG Oncology as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.